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Uracil-DNA glycosylase (UDG) is an enzyme involved in the base
excision repair pathway. It specifically removes uracil from both
single-stranded and double-stranded DNA. The genome of the
Bacillus subtilis phage29 is a linear double-stranded DNA with a
terminal protein covalently linked at each 5-end. Replication of
29 DNA starts by a protein-priming mechanism and generates
intermediates that have long stretches of single-stranded DNA. By
using in vivo chemical cross-linking and affinity chromatography
techniques, we found that UDG is a cellular target for the early viral
protein p56. Addition of purified protein p56 to B. subtilis extracts
inhibited the endogenous UDG activity. Moreover, extracts from
29-infected cells were deficient in UDG activity. We suggested
that inhibition of the cellular UDG is a defense mechanism devel-
oped by29 to prevent the action of the base excision repair path-
way if uracil residues arise in their replicative intermediates. Pro-
tein p56 is the first example of a UDG inhibitor encoded by a non-
uracil-containing viral DNA.
Uracil in DNA may arise from spontaneous deamination of cytosine
and from the occasional use of dUTP instead of dTTP during DNA
replication. Hydrolytic deamination of cytosine generates G:U mis-
matches that cause G:C to A:T transition mutations. To maintain the
genome integrity, most prokaryotic and eukaryotic cells rapidly elimi-
nate uracil fromDNAby the base excision repair (BER)2 pathway,which
is initiated by the uracil-DNA glycosylase (UDG) enzyme. UDGs have
an unusually broad phylogenetic distribution. Some DNA viruses, such
as herpesviruses and poxviruses, also encode a UDG activity, whereas
the human immunodeficiency virus, type 1, packages cellular UDG
(UNG2 enzyme) into virus particles. In these instances, the UDG activ-
ity appears to have an important role in virus replication (1).
The UDG enzyme hydrolyzes the N-glycosidic bond between the
uracil residue and the deoxyribose sugar of the DNA backbone, gener-
ating an apurinic-apyrimidinic (AP) site. The first UDG activity
reported was purified from Escherichia coli cells (2). Since then,
enzymes highly homologous to the archetypal E. coli UDG have been
identified in numerous organisms, including human cells (Family-1
UDGs) (3). Studies on substrate specificity showed that Family-1 UDGs
efficiently remove uracil residues from both single-stranded and dou-
ble-stranded DNAs, often with preference for the single-stranded sub-
strates (4, 5). The AP site generated by the UDG enzyme is further
recognized by an AP endonuclease, which cleaves the phosphodiester
bond of the DNA backbone 5 to the AP site. Several AP endonucleases
are active not only on double-stranded DNAs but also on single-
stranded DNAs (6–8). Further repair can be accomplished via two
pathways that involve different subsets of enzymes and result in replace-
ment of one (short patch pathway) ormore (long patch pathway) nucle-
otides (9).
Over the course of evolution, bacteriophages have developed unique
proteins that bind to and inactivate critical cellular proteins, shutting off
key processes. The DNA genome of phage PBS2 contains uracil in place
of thymine residues (10). Following infection of Bacillus subtilis, this
phage induces various enzymatic activities that ensure the use of dUTP
rather than dTTP during viral DNA synthesis. In addition, phage PBS2
encodes an inhibitor of the B. subtilis UDG enzyme, named Ugi, which
is essential for the preservation of uracil residues incorporated into
phage DNA (11–13). Some studies showed that Ugi (84 amino acids)
specifically inactivates Family-1 UDGs (13, 14). The x-ray crystal struc-
tures of Ugi in complex with different UDGs revealed that Ugi mimics
electronegative and structural features of duplex DNA (15–17).
Unlike phage PBS2, the genome of the B. subtilis phage 29 does not
contain uracil residues. It is a linear double-stranded DNA, with a ter-
minal protein (TP) covalently linked at both 5-ends. Replication of29
DNA starts nonsimultaneously at either DNA end, where the replica-
tion origins are located, by a protein-priming mechanism (18). Electron
microscopy studies revealed twomain types of29 replicative interme-
diates in infected cells, named type I and type II (19, 20) (Fig. 1A). Type
I intermediates are unit-length linear double-stranded DNA molecules
with one or more single-stranded branches of varying lengths. Type II
intermediates are unit-length linear molecules in which a region of the
DNA starting from one end is double-stranded, and the adjacent region
containing the other end is single-stranded. Thus, both replicative inter-
mediates have long stretches of single-stranded DNA. Most unexpect-
edly, during the functional characterization of the early viral protein p56
(56 amino acids), we found that p56 interacted with the B. subtilisUDG
and inhibited its activity. Furthermore, we demonstrated that extracts
from 29-infected cells lacked UDG but not AP endonuclease activity.
UDG inhibitors encoded by non-uracil containing viral DNAs were not
identified previously. We propose that inhibition of the host UDG by
protein p56 ensures the integrity of the 29 replicative intermediates if
uracil residues arise either by cytosine deamination or dUMP
misincorporation.
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EXPERIMENTAL PROCEDURES
Bacterial Strains, Bacteriophages, and Plasmids—B. subtilis 110NA
(23), a nonsuppressor (su) strain, and B. subtilis MO-101-P (24), a
suppressor strain (su44), were used. Phage 29 sus4 (56) (23) was used
in cross-linking experiments. This phage carries a suppressor-sensitive
mutation in gene 4, which encodes an activator of the late transcription
(25). Phage 29 sus14(1242) (26) was used to measure UDG activity in
extracts of infected cells. This phage contains a suppressor-sensitive
mutation in gene 14, which encodes the holin protein (27). Thus, cell
lysis is delayed. Phage stocks were prepared as reported (28).
To construct plasmid pCR2.1-TOPO.p56, the TOPO TA cloning kit
(Invitrogen) was used. Basically, a 29 DNA region, which contains
gene 56, was amplified by the PCR using the oligonucleotides 5-CG-
CATTGTATGAGCTTTCTAGGATGG-3 and 5-GCAGGGAAT-
TCTGCAGTCAAAGGACTTTATC-3 as primers. The 267-bp PCR-
synthesized fragment was cloned into the E. coli expression vector
pCR2.1-TOPO (Invitrogen), which is based on the T7 promoter. Trans-
formed cultures of the E. coli TOP10 strain were plated on LB plates
containing 50 g/ml of kanamycin. To construct plasmid pPR53.p56,
the 272-bp PstI restriction fragment of plasmid pCR2.1-TOPO.p56,
which carries gene 56, was inserted into the PstI site of the B. subtilis
constitutive expression vector pPR53, which is based on the PR pro-
moter of phage  (29). The B. subtilis strain YB886 (30) was used for
cloning, and transformants were selected for phleomycin resistance (0.8
g/ml). Gene 56 was engineered to encode a FLAG-tagged p56 protein
(p56FLAG). To this end, a two-step mutagenesis method was used. In
the first step, gene 56 was amplified by PCR using plasmid pPR53.p56 as
template and the oligonucleotides A (5-CCTCTAGAGTCGACCTG-
CAG-3) and B (5-GTCATCGTCATCCTTATAGTCAGGACTT-
TATCCAACCTTAG-3) as primers. In the second step, the 298-bp
PCR-synthesized fragment was used as template and the oligonucleo-
tides A and C (5-CCCTCAGGGCTGCAGTTATTACTTGTCAT-
CGTCATCCTTATAGTC-3) as primers. Oligonucleotides A and C
include a PstI restriction site (boldface). The 322-bp PCR-amplified
fragment was further digested with PstI, and the 293-bp digestion prod-
uctwas inserted into the PstI site of theB. subtilis vector pPR53 (plasmid
pPR53.p56FLAG).
Phage Growth under One-step Conditions—B. subtilis 110NA cells
were exponentially grown at 30 °C in LB medium supplemented with 5
mM MgSO4 to an absorbance at 560 nm (A560) equivalent to108 col-
ony-forming units (cfu) per ml. The culture was then infected with 29
at amultiplicity of 5–10. After 10min of incubationwith gentle shaking,
unadsorbed phages were eliminated by centrifugation of the infected
culture. Cells were resuspended in the same volume of medium and
incubated with vigorous shaking for the indicated time.
Immunoblotting—Gel-separated proteins were transferred electro-
phoretically to Immobilon-Pmembranes (Millipore) using aMiniTrans
Blot (Bio-Rad) at 100mA and 4 °C for 60min. Transfer buffer contained
25 mM Tris, 192 mM glycine, 20% methanol. Membranes were probed
with anti-p56 serum for 60 min. Antigen-antibody complexes were
detected using anti-rabbit horseradish peroxidase-conjugated antibod-
ies and ECL Western blotting detection reagents (Amersham Bio-
sciences). For quantitative immunoblotting (29), cell extracts were pre-
pared from a known number of viable cells, which was determined
before phage addition. Increasing amounts of the cell extract and known
amounts of purified protein p56 were run in the same gel.
In Vivo Chemical Cross-linking—Bacteria were washed with 50 mM
Hepes, pH 8.0, and concentrated 20-fold in buffer P (50 mM Hepes, 10
mM EDTA, 20% sucrose, pH 8.0). The cross-linker dithiobis(succinimi-
dylpropionate) (DSP) (Pierce) was dissolved in Me2SO just before use.
DSP was added to the culture at the indicated concentration. After
incubation at room temperature for 20 min, Tris-HCl, pH 7.5, was
added at a final concentration of 150 mM to quench the reaction. Cells
were harvested by centrifugation, resuspended in loading bufferwithout
-mercaptoethanol (60 mM Tris-HCl, pH 6.8, 2% SDS, 30% glycerol),
and disrupted by sonication.
Isolation of p56FLAG Complexes—B. subtilis 110NA cells carrying
plasmid pPR53.p56FLAGwere exponentially grown in LBmediumcon-
taining phleomycin (0.8 g/ml) at 30 °C to an A560 equivalent to 108
cfu/ml. Cells were concentrated 10-fold in buffer TBS (50mMTris-HCl,
pH 7.5, 150 mM NaCl) and disrupted by French pressure treatment
(20,000 p.s.i.). The whole-cell extract was centrifuged at 7,000 rpm and
4 °C in a Sorvall SS.34 rotor for 10 min. The supernatant was loaded
onto an anti-FLAG M2 affinity column (Sigma) under gravity flow.
Later, the column was extensively washed with buffer TBS. Proteins
bound to the column were eluted with buffer TBS containing FLAG-
peptide (500 g/ml) (Sigma). Eluted proteins were precipitated with
acetone and resuspended in loading buffer (60mMTris-HCl, pH 6.8, 2%
SDS, 5% -mercaptoethanol, 30% glycerol).
Peptide Mass Fingerprinting—Gel-separated proteins were stained
with SyproRuby and subjected to in situ digestion with trypsin, as
described (31). Peptide masses were measured with a matrix-assisted
laser desorption/ionization time of flight mass spectrometer Autoflex
(Bruker Daltonic; Bremen, Germany) equipped with a reflector and
employing 2,5-dihydroxybenzoic acid as matrix and a Anchor-Chip
surface target. Themass spectrawere fitted to data bases by the program
Mascot (32).
Purification of Protein p56—E. coli BL21(DE3) cells carrying plasmid
pCR2.1-TOPO.p56 were grown in LB medium containing kanamycin
(50 g/ml) at 34 °C. When the culture reached an A560 of 0.9, isopropyl
1-thio--D-galactopyranoside was added to a final concentration of 0.5
mM. After 30 min, cells were incubated with rifampicin (120 g/ml) for
75 min. Cells were collected by centrifugation and frozen at 70 °C
before being used. Protein p56 was purified under ice-cold conditions
using the following protocol. Cells were ground with alumina in buffer
A (50mMTris-HCl, pH 7.5, 1 mM EDTA, 7mM -mercaptoethanol, 5%
glycerol) containing 0.65 M NaCl. After removal of alumina and cell
debris by centrifugation, the cleared lysate was mixed with polyethyl-
eneimine (0.3%), incubated on ice for 20 min, and centrifuged at 12,000
rpm in a Sorvall GSA rotor for 10min. The supernatant was made 0.3 M
NaCl with buffer A and centrifuged as before for 20 min. The resulting
pellet was washed with buffer A containing 0.7 M NaCl. After centrifu-
gation (12,000 rpm in a Sorvall SS34 rotor for 20 min), the supernatant
was processed by stepwise ammonium sulfate precipitation at 65, 45,
and finally 30%. Proteins were recovered from the 30% ammonium sul-
fate supernatant by raising it to 50% ammonium sulfate. This last pellet
was resuspended in buffer A to a final salt concentration of 55 mM
(estimated by conductivity measurements). The protein preparation
was then loaded onto a Mono Q column equilibrated with buffer A
containing 55 mM NaCl. Protein p56 was eluted from the column with
0.3 M NaCl. This fraction was further loaded onto a 15–30% glycerol
gradient and subjected to centrifugation at 62,000 rpm in a Beckman
SW.65 rotor for 20 h. Fractions containing p56 were pooled, precipi-
tated with ammonium sulfate to 70% saturation, resuspended in buffer
A containing 50% glycerol, and stored at70 °C.
Interaction between p56 and E. coli UDG inVitro—The reactionmix-
ture (10 l) contained 20 mM Tris-HCl, pH 8.0, 1 mM dithiothreitol, 1
mMEDTA, 20mMNaCl, 20% glycerol, 2g of protein p56, and 0.2g of
E. coli UDG (New England Biolabs). After incubation at room temper-
ature for 15min, the sample was kept at 4 °C for 15min and analyzed by
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nondenaturing PAGE (16% polyacrylamide). Gel electrophoresis was
performed at 4 °C.
UDG and AP Endonuclease Activities in B. subtilis Extracts—B. sub-
tilis strain 110NA was grown to mid-log phase in LB medium at 30 °C
(108 cfu/ml). Cells were concentrated 10-fold in buffer U (50 mM
Tris-HCl, pH 8.0, 200 mM NaCl, 12 mM -mercaptoethanol, 1 mM
EDTA) containing a protease inhibitor mixture (1 tablet of Complete,
Mini, EDTA-free per 10 ml) from Roche Applied Science. Cells were
disrupted by French pressure treatment (20,000 p.s.i.). After centrifuga-
tion at 7,000 rpm and 4 °C in a Sorvall SS.34 rotor for 10 min, the
supernatant (extract) was kept at 4 °C for up to 2 weeks. Total protein
concentration (1.35mg/ml)was determined by the Lowrymethodusing
a NanoDropND-1000 spectrophotometer. Tomeasure UDG activity, a
34-mer oligonucleotide containing a single uracil residue at position 16
(ssDNA-U16) (from Isogen) was used as substrate. It was 5-labeledwith
[-32P]ATP (3,000 Ci/mmol) (Amersham Biosciences) and T4 polynu-
cleotide kinase (New England Biolabs). Reaction mixtures (20 l) con-
tained the indicated amount of extract and radiolabeled substrate in
buffer U carrying protease inhibitors (see above). After incubation at
37 °C for 10min, samples were treated with NaOH to a final concentra-
tion of 0.2 M and heated at 90 °C for 30 min. Samples were then dried in
a SpeedVac, resuspended in 10 l of formamide loading buffer (95%
formamide, 20 mM EDTA, 0.05% xylene cyanol, 0.05% bromphenol
blue), and subjected to electrophoresis in 8 M urea, 20% polyacrylamide
gels. TomeasureAP endonuclease activity, the radiolabeled ssDNA-U16
oligonucleotidewas incubatedwith E. coliUDG (NewEngland Biolabs),
generating a 34-mer oligonucleotide with an AP site at position 16
(ssDNA-AP16). This product was used as substrate. Reaction mixtures
(20 l) contained 50 mM Tris-HCl, pH 8.0, 12 mMNaCl, 12 mM -mer-
captoethanol, 10 mM MgCl2, and the indicated amount of extract and
radiolabeled substrate. After incubation at 37 °C for 15min, 12l of the
formamide loading buffer was added to the reactions. Purified human
AP endonuclease (APE1) was purchased from Trevigen.
RESULTS
Protein p56 Accumulates throughout the 29-Infective Cycle—The
left end of the 29 genome contains genes 6, 5, 4, 3, 2, and 1 (Fig. 1B).
With the exception of gene 4, which encodes a transcriptional regulator
protein, the mentioned genes are involved in phage DNA replication
(18, 33). Analysis of the nucleotide sequence downstream gene 1
revealed the existence of an open reading frame (ORF56) that would
encode an acidic protein of 56 amino acids (protein p56). ORF56 would
bemainly transcribed from two strong early promoters, namedA2c and
A2b, into a polycistronic RNA (Fig. 1B). Both promoters are partially
repressed at late times of infection (25). In addition, ORF56 would be
transcribed from theweak early promoterA1IV, which is locatedwithin
gene 2 (34–36). To analyze whether protein p56was synthesized during
29 infection, B. subtilis cells were infected with phage 29 under one-
step growth conditions. At different times after infection, whole-cell
extracts were obtained by sonication, and total proteins were analyzed
by immunoblotting. A protein recognized by antibodies against p56
accumulated throughout the 29 lytic cycle (Fig. 2A). Overexposure of
the blot shown in Fig. 2A allowed detection of p56 at 15 min of 29
infection (not shown).Quantitative immunoblotting indicated that pro-
tein p56 was present in104 molecules per cell at early stages of infec-
tion (15 min), and it increased up to 105 molecules per cell at late
stages of infection (50 min).
Protein p56 Interacts with a Host Protein during 29 Infection—To
find out whether protein p56 interacted with a viral and/or cellular
protein during 29 infection, we carried out in vivo chemical cross-
linking experiments. Specifically, at 40 min of viral infection, cells were
incubated with dithiobis(succinimidylpropionate) (DSP). This homobi-
functional cross-linker reacts significantly with the -amine of lysine
residues. Protein p56 has four lysines. Following this treatment, whole-
cell extracts were prepared by sonication. Total proteins were separated
by SDS-Tricine-PAGE and analyzed by immunoblotting using antibod-
ies against p56. As control, noninfected cells were incubated with DSP
(Fig. 2B). The anti-p56 antibodies cross-reacted with a bacterial protein
that migrated at 20 kDa (Fig. 2B, protein X). In infected cells treated
withDSP, in addition to protein p56, amajor specific cross-linked prod-
uct migrating at 35 kDa (p56 complex) was detected. We further
investigated whether the p56 complex was formed in the absence of
other viral proteins. To this end, gene 56 was cloned into the B. subtilis
expression vector pPR53 (29). Cells carrying the recombinant plasmid
(pPR53.p56) constitutively synthesized protein p56 at levels slightly
lower than those detected at 40 min of phage infection (Fig. 2B). When
FIGURE 1. A, types of 29 replicative intermediates. The genome of 29 is a linear double-stranded DNA with a TP covalently linked at each 5-end (parental TP;white circle). A free
moleculeof theTP (primer TP;black circle) provides thehydroxyl groupneededby theviralDNApolymerase to startDNAsynthesis at both29DNAends (protein-priming replication
mechanism) (21). During elongation,29 DNApolymerase catalyzes highly processive polymerization coupled to strand displacement (22), and consequently, complete replication
of both strandsproceeds continuously fromeachprimingevent. See Introduction formoredetails.B, genetic and transcriptionalmapof the left endof the29genome.Only relevant
features are shown.White arrows indicate the location of genes previously identified. The black arrow indicates the position of gene 56, which has been identified in this work. Genes
6 (double-strandedDNAbinding protein), 5 (single-strandedDNAbinding protein), 3 (TP), and 2 (DNApolymerase) are essential for in vivo29DNA replication (18). Gene 1 encodes
amembrane-localized protein involved in themembrane association of29DNA replication. This protein enhances the rate of viral DNA replication in vivo (33).Wavy lines represent
transcripts from the indicated early promoters. The position of the transcriptional terminator TA1 is indicated.
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these cells were incubated with DSP, the 35-kDa p56 complex was
again detected. Hence, the viral protein p56 was able to interact with a
host protein both during the infective process and in the absence of viral
components. Taking into account the molecular mass of p56 (6.6 kDa)
and DSP (0.4 kDa), the molecular mass of the host protein would be
28 kDa.
Protein p56 Interacts with UDG—To identify the cell target for pro-
tein p56, gene 56 was engineered to encode a FLAG-tagged p56 protein
(p56FLAG). This variant of p56 carries the peptide DYKDDDDK fused
to its C-terminal end. The mutant gene was cloned into the B. subtilis
expression vector pPR53 (plasmid pPR53.p56FLAG). By immunoblot-
ting, we verified that B. subtilis cells carrying the recombinant plasmid
constitutively synthesized protein p56FLAG at levels similar to those
detected for p56 at late stages of 29 infection (not shown). Extracts
from these cells were applied to an anti-FLAG affinity column. The pure
FLAG peptide was then used to elute p56FLAG. As a negative control,
extracts from B. subtilis cells harboring plasmid pPR53 were used. The
eluted proteins were separated by SDS-Tricine-PAGE and stained with
SyproRuby (Fig. 3A). Protein p56FLAG co-eluted with five proteins
(named A to E) that were absent in the control sample.With the excep-
tion of protein E, such proteins were identified by peptide mass finger-
printing using the MASCOT search program (32). Proteins A and B
were identified as the E2 (47.5 kDa; dihydrolipoamide acetyltransferase)
and E3 (49.7 kDa; dihydrolipoamide dehydrogenase) subunits of the
pyruvate dehydrogenase multienzyme complex (PDH), respectively.
Their mobility in denaturing polyacrylamide gels was anomalous, as
reported previously (39). Protein C was a degradation product of the
PDH E2 subunit (E2*), whereas protein D was identified as the UDG
DNA repair enzyme (26 kDa). Therefore, the affinity chromatography
results suggested that protein p56 interacted with a subunit of the PDH
complex (see “Discussion”) andwithUDG. Because the in vivo chemical
cross-linking experiments (Fig. 2B) revealed that a protein of28 kDa
was a cell target for p56, we performed additional experiments to con-
firm the potential interaction between p56 and UDG (see below).
The B. subtilis UDG is highly homologous to the E. coli UDG (Fami-
ly-1 UDGs) (3, 40). Therefore, we analyzed whether protein p56 was
able to interact with UDG purified from E. coli. To this end, protein p56
was incubated with E. coli UDG for 15 min at room temperature, and
the reaction mixture was analyzed by nondenaturing PAGE. As shown
in Fig. 3B, free protein p56, but not free UDG, was detected. Moreover,
a protein band migrating faster than UDG was visualized (p56-UDG-
coli). This band contained p56 and UDG, as confirmed by immunoblot
analysis and peptide mass fingerprinting, respectively (not shown). In
conjunction with the above, this result demonstrated that protein p56
forms a complex with UDG.
Protein p56 Functions as an Inhibitor of the B. subtilis UDG—Fami-
ly-1 UDGs are able to excise uracil base efficiently from both single-
stranded and double-strandedDNAs. Furthermore, they are specifically
sensitive to Ugi (3), a UDG inhibitor encoded by phage PBS2. Removal
of uracil by UDGs generates an AP site that can be processed by hydro-
lytic AP endonucleases. In the absence of an AP endonuclease activity,
chemical cleavage of the DNA at the AP site can be achieved by treat-
ment with heat and alkali.
To investigate whether protein p56 was an inhibitor of the B. subtilis
UDG, we set up an assay tomeasure UDG activity in B. subtilis extracts.
In the first experiment, a 34-mer single-stranded oligonucleotide con-
taining a single uracil residue at position 16 (ssDNA-U16) was incubated
FIGURE 2. A, synthesis of protein p56 throughout the 29 lytic cycle. B. subtilis 110NA
cells growing in LB medium at 30 °C were infected with the wild-type phage at a multi-
plicity of infection of 5. Phage addition marked the zero time of the experiment. Total
lysis of the culture was observed 70 min after infection. At the indicated times, cell
extractswereprepared, and total proteinswere separatedby SDS-Tricine-PAGE (37). The
amount of extract loaded onto the gel corresponds to 108 cells. The gel was processed
for Western blotting using anti-p56 serum. Purified protein p56 was run in the same gel
(lane C). B, interaction of protein p56with an28 kDahost protein. B. subtilis 110NA cells
growing in LB medium at 30 °C were infected with 29 sus4 (56) under one-step condi-
tions. In these cells, the29 regulatory protein p4 is not synthesized, and consequently,
late viral transcription is not activated (25). The late genes encode components of the
viral capsids, proteins involved in phagemorphogenesis and those required for cell lysis.
Hence, the cells remain intact at late stages of infection, which is needed to perform in
vivo chemical cross-linking experiments (38). B. subtilis 110NA cells carrying plasmid
pPR53.p56 were exponentially grown in LB medium at 30 °C to 108 cfu/ml. DSP (200
M) was used as cross-linker. Total proteins were separated by SDS-Tricine-PAGE (37).
The gelwas processed for immunoblotting using anti-p56 serum. Themolecularmass of
pre-stained proteins used as markers (Invitrogen) is indicated on the left in kDa. Purified
protein p56 was run in the same gel (lane C).
FIGURE 3. A, affinity purification of p56FLAG complexes. Anti-FLAG M2 affinity columns
(Sigma) were used. Protein p56FLAG and associated proteins were eluted by competi-
tion with FLAG peptide. After acetone precipitation, eluted proteins were resolved by
SDS-Tricine-PAGE and stained with SyproRuby (Molecular Probes). Molecular mass
markers are indicated on the right in kDa. The peptide mass fingerprint search program
Mascot and the NCBI data base were used for protein identification. Accession numbers
are as follows: A, gi 16078524; B, gi 16078525; C, gi 16078524; and D, gi 16080848. B,
interaction between protein p56 and E. coli UDG in vitro. Protein p56 (2 g) and UDG
purified from E. coli (0.2 g; New England Biolabs) were mixed and analyzed by nonde-
naturing PAGE (16% polyacrylamide). The gel was stained with SyproRuby.
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with increasing amounts of aB. subtilis extract. After 10min,NaOHwas
added to the reaction mixtures. As shown in Fig. 4A, a cleavage product
was generated using 0.2 g of extract. Moreover, the substrate was
almost totally cleaved when 1.6 g of extract were used. The same
cleavage product was detected when the substrate was incubated with
UDG purified from E. coli. Therefore, the B. subtilis extract was capable
of removing uracil from single-stranded DNA generating an AP site
(UDG activity). However, under the assayed conditions, the extract
lacked AP endonuclease activity, because cleavage of the substrate did
not occur when the reactions were not treated with NaOH (Fig. 4A).
Furthermore, the UDG activity of the B. subtilis extract was sensitive to
the presence of Ugi (Fig. 4B) and was able to excise uracil from double-
strandedDNA bearing a G:Umismatch (not shown). Collectively, these
results demonstrated the presence of Family-1 UDG in the B. subtilis
extract.
We next examined whether the viral protein p56 was able to inhibit
the UDG activity of the B. subtilis extract (Fig. 4C). To this end, the
ssDNA-U16 substrate was incubated with 1.6 g of extract in the pres-
ence of different amounts of purified protein p56 (from 0.5 to 16 ng).
After 10 min, NaOH was added to the reactions. A decrease in the
amount of the cleavage product was detected with 2 ng of p56. More-
over, cleavage of the substrate did not take place in the presence of 8 ng
of p56. Therefore, these results showed that protein p56 acts as an
inhibitor of the B. subtilis UDG.
Inhibition ofUDGActivity in29-InfectedCells—If protein p56 func-
tions as a UDG inhibitor during 29 infection, extracts from infected
cells should be deficient in UDG activity. To test this hypothesis, B.
subtilis cells were infected with 29 under one-step growth conditions,
and extracts were prepared at 30min of infection. Then the ssDNA-U16
substrate was incubated, in the absence of Mg2, with increasing
amounts of the infected extract, and after 10 min NaOH was added to
the reactions (Fig. 5A). As controls, total cleavage of the substrate was
obtained with purified E. coli UDG and with extract from noninfected
cells. On the contrary, nearly 90% of the substrate remained intact when
it was incubated with 0.2g of the infected extract. This percentage did
not significantly decrease when higher amounts of infected extract (up
to 6.4 g) were used. However, total cleavage of the substrate was
observed when E. coli UDG was added to the infected extract (3.2 g).
Therefore, extracts from 29-infected cells showed a drastic reduction
in UDG activity.
AP sites generated byUDGs can be processed by hydrolytic AP endo-
nucleases. Themajor AP endonuclease inB. subtilis is the ExoA protein.
Like human AP endonuclease APE1, ExoA catalyzes the cleavage of the
phosphodiester bond 5 to the AP site, leaving a 3-hydroxyl group.
Moreover, it was shown that both AP endonucleases cleave single-
stranded oligonucleotides containing an AP site (7, 8). To find out
whether other base excision DNA repair enzymes were inactivated dur-
ing 29 infection, we measured AP endonuclease activity in extracts
from noninfected and infected cells. In this assay, a 34-mer single-
stranded oligonucleotide with a single AP site at position 16 (ssDNA-
AP16) was used as substrate. As positive control, the human APE1
enzyme was used. As shown in Fig. 5B, AP endonucleolytic activity was
detected in the infected extract (1.6 g), as well as in the noninfected
extract (1.6g). From these results, we conclude that UDG activity, but
not AP endonuclease activity, is inhibited by p56 during 29 infection.
DISCUSSION
Most prokaryotic and eukaryotic cells encode the UDG enzyme,
which is involved in the BERpathway. It specifically removes uracil from
DNA. In this work, we have demonstrated that the lytic phage 29
encodes an inhibitor of the B. subtilis UDG. This inhibitor is an acidic
protein of 56 amino acids, named p56. Hence, protein p56 is the first
example of a UDG inhibitor encoded by a non-uracil containing viral
DNA.
We have measured UDG activity in B. subtilis extracts. This enzy-
matic activity was Mg2-independent and excised uracil residues from
both single-stranded and double-stranded DNAs. Addition of purified
protein p56 to the B. subtilis extract inhibited the endogenous UDG
activity. Moreover, a drastic reduction in UDG activity was observed in
extracts from 29-infected cells, whereas the AP endonuclease activity
remained intact. Therefore, the early viral protein p56 functions as an
inhibitor of the cellular UDGduring29 infection. This conclusion was
supported by protein-protein interaction experiments. A complex
formed by p56 and a host protein of28 kDa was detected in infected
cells using chemical cross-linking techniques.Moreover, UDG (26 kDa)
co-eluted with p56FLAG when extracts of B. subtilis cells producing
p56FLAG and anti-FLAG affinity columns were used. Protein p56 also
formed a complex with E. coli UDG in vitro, as determined by native
PAGE. B. subtilis UDG has strong sequence homology to E. coli UDG
(40). Both enzymes belong to a family of highly conserved DNA glyco-
sylases, which remove uracil from both single-stranded and double-
stranded DNAs (3).
By affinity chromatography, we found that in addition to UDG, E2
and E3 co-eluted with protein p56FLAG. E2 and E3 are components of
the PDHmultienzyme complex, which catalyzes the irreversible oxida-
tive decarboxylation of pyruvate to acetyl-coenzymeA. PDH complexes
of Gram-positive bacteria have a core of 60 E2 subunits with icosahedral
symmetry (41). Besides its role in oxidative metabolism, the E2 subunit
appears to have DNA binding activity (42, 43). The low isoelectric point
of protein p56 suggests that it might act as a double-stranded DNA
mimic, like the UDG inhibitor Ugi and the highly acidic protein HI1450
from Haemophilus influenzae (15, 16, 44). If this were the case, co-
FIGURE 4. A, UDG activity in B. subtilis extracts. The 5-end 32P-labeled ssDNA-U16 sub-
strate (S) (0.55 ng) was incubatedwith the indicated amount of extract in the absence of
Mg2. After 10 min, the reaction mixtures were treated or not with NaOH. Formation of
the cleavageproduct (P) wasmonitoredby autoradiography after resolutionon8Murea,
20% polyacrylamide gels. As internal control, UDG from E. coli (0.5 units; New England
Biolabs) was used. B, inhibition of the B. subtilis UDG activity by Ugi. The substrate was
incubated with 1.6 g of extract in the absence or presence (0.1 units) of Ugi (New
England Biolabs). Reactions were treated with NaOH. C, inhibition of the B. subtilis UDG
activity by protein p56. The indicated amount of p56 was added to 1.6 g of extract.
Reactions were treated with NaOH.
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elution of the E2 subunit with p56FLAG could be related to the ability of
E2 to interact with DNA. Nevertheless, at present, it is unknown
whether a p56-E2 complex is formed during 29 infection.
Inhibition of the cellular UDG activity after phage infection was
established previously in two systems. The first example was the inhi-
bition of the B. subtilis UDG after infection with phage PBS2 (11). The
need for this inhibition was obvious, because the DNA genome of PBS2
contains uracil instead of thymine residues. Thus, phage PBS2 has
developed a defensive mechanism against the action of the host UDG.
The UDG inhibitor encoded by phage PBS2 was identified as an acidic
protein of 84 amino acids (Ugi) (13). Less obvious was the inhibition of
the E. coliUDG after infection with phage T5, because its DNA genome
does not contain uracil residues. In this case, the UDG inhibitor has not
yet been identified, although early studies suggested that it could be a
pre-early phage-encoded protein (45). In fact, the pre-early region of
phage T5 contains six small open reading frames that presumably
encode host function inhibitors (46).
Why does phage 29 encode an inhibitor of the cellular UDG? We
think that this inhibition is related to the mechanism of 29 DNA rep-
lication. As depicted in Fig. 6, replication of the linear 29 DNA starts
nonsimultaneously at both ends, where the replication origins are
located, using a free molecule of the TP as primer. Once initiated, rep-
lication proceeds by a strand displacement mechanism, and conse-
quently, replicative intermediates (type I and type II) with long stretches
of single-stranded DNA are generated (18). If uracil arises in the 29
genome, either by misincorporation of dUMP or by cytosine deamina-
tion, and the damage is not repaired before DNA replication, type I
replicative intermediates carrying a uracil residue on single-stranded
DNA could appear. The presence of uracil in the replicative intermedi-
ate could recruit components of the cellular BER pathway, such as
UDGs and AP endonucleases. As shown in this work, B. subtilis cells
synthesize an enzymatic activity that efficiently removes the aberrant
base uracil from single-stranded DNA, generating an AP site. The sub-
sequent action of an AP endonuclease activity would introduce a nick
into the phosphodiester backbone with accompanying loss of the ter-
minal DNA region. It has been shown that the ExoA protein of B. sub-
tilis has AP endonuclease activity on single-stranded DNA (7). When
two replication forks moving in opposite directions merge, type II rep-
licative intermediates are formed. ThenDNA synthesis would continue,
and a shorter viral DNA molecule lacking one parental TP would be
generated. Therefore, the action of the cellular UDG on single-stranded
DNA regions of the 29 replicative intermediates would be harmful for
viral replication.
Uracilation of DNA represents a constant threat to the survival of
many organisms, including viruses. More than likely, phage 29 has
developed alternative strategies to protect its genome from uracilation.
One possibility may be the recruitment of the cellular deoxyuridine
triphosphatase enzyme (dUTPase), which maintains a low dUTP:dTTP
ratio and, consequently, minimizes the misincorporation of uracil into
DNA. Most interestingly, herpesviruses, poxviruses, and certain retro-
viruses encode dUTPase, whose function is thought to be associated
with the ability of these viruses to replicate in cells that produce low
levels of dUTPase (1). Another possible strategy of 29 to counteract
the accumulation of uracil in its genome may be the recruitment of a
mismatch-specific UDG activity. For example, E. coli encodes a double-
strand specific enzyme capable of removing uracil residues from G:U
mismatches arising through spontaneous cytosine deamination. Such
an enzyme is related to the human thymine-DNA glycosylase and is
insensitive to inhibition by Ugi (47).
The generation of replicative intermediates containing long stretches
of single-stranded DNA is a feature of the protein-primed mechanism
FIGURE 6.Model of genome instability produced by the action of UDG on 29 rep-
licative intermediates. Parental TP (white circle) and primer TP (black circle) are indi-
cated. Dashed lines indicate newly synthesized viral DNA. See “Discussion” for details.
FIGURE 5.A, lack of UDG activity in extracts of29-
infected cells. The 5-end 32P-labeled ssDNA-U16
substrate (S) (0.55 ng)was incubatedwith the indi-
cated amount of extract in the absence of Mg2.
Reactions were treated with NaOH. See legend to
Fig. 4A for more details. B, AP endonuclease activ-
ity in extracts of29-infected cells. The 5-end 32P-
labeled ssDNA-AP16 substrate (S) (1.6 ng) was
incubated with 1.6 g of the indicated extract in
the presence of Mg2. As internal control, human
AP endonuclease (APE1; 0.1 units; from Trevigen)
was used.
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of DNA replication. Therefore, it is expected that gene 56 is conserved
in the genome of other 29-related phages. In the case of phage B103,
there is an open reading frame that would encode a 56-amino acid
protein, whose deduced sequence has a high level of homology to pro-
tein p56 (64% identity and 75% similarity) (48). Furthermore, in phage
GA-1, which is the most distantly 29-related phage, there is an open
reading frame that would encode a 130-amino acid protein. The region
of this putative protein spanning amino acids 27 and 82 shows 23%
identity and 27% similarity with protein p56, suggesting that they may
have similar functions.3
To conclude, protein p56 of phage 29 functions as an inhibitor of
the cellular Family-1 UDG. This inhibition is likely a defense mecha-
nism developed by29 and29-related phages to prevent the action of
the BER pathway if uracil residues arise in the replicative intermediates.
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